How many investments has BayMed Venture Partners made?

BayMed Venture Partners has 12 tracked investments, 1 of which have exited via acquisition or IPO.

What stage does BayMed Venture Partners invest at?

BayMed Venture Partners invests at the Pre-Seed, Seed, Series A, Series B stages.

What sectors does BayMed Venture Partners focus on?

BayMed Venture Partners focuses on Digital Health, Healthtech, Medical Devices.

Where is BayMed Venture Partners located?

BayMed Venture Partners is headquartered in San Francisco, US.

Who does BayMed Venture Partners co-invest with?

BayMed Venture Partners most often shares deals with Broadview Ventures, Arboretum Ventures, ARCH Venture Partners, among 21 tracked co-investors.

BayMed Venture Partners

Venture capital

San Francisco · Pre-Seed–Series B · 7 people tracked

★ Follow + Add to CRM ⤳ Find an introduction

✨ Fox Verdict

Investment thesis

BayMed Venture Partners focuses on maturing early-stage medical device and digital health companies in North America and Israel, targeting important unmet clinical needs with disruptive, differentiated innovation. The firm draws on deep clinical and operational expertise and cross-functional support to help portfolio companies succeed. It emphasizes global sourcing and deal flow through extensive industry relationships, and applies a results-driven, exit-focused methodology, acting as a true partner to companies to drive growth and value for portfolio companies, investment partners, and the broader healthcare system.

Invests inDigital Health Healthtech Medical Devices Israel North America San Francisco United States

Source: firm website, verified Aug 11, 2026.

Stage

Pre-Seed–Series B

San Francisco, CA, US

Instruments

Equity

Founded

2020

Tracked investments

Team · 7 people

from the firm's website & public directories

Gary Gershony, MD· Founding General Partner

Dr. Gershony founded and served as Chief Medical Officer and board member for Vascular Solutions and AngioScore, acquired for a combined $1.3B. An interventional cardiologist and experienced healthcare venture and angel investor, he holds 11 patents and has led over 50 clinical trials with more than 100 peer-reviewed publications.

Gary Gershony· Founding General Partnerin

g•••@baymedvp.comreveal

Neil Meyer· Founding General Partnerin

Neil has over 20 years in the healthcare sector as an investor at firms including Partner Fund Management, Citadel, and JPMorgan. He also led investor relations and strategic finance at Thoratec Corporation before its $3.4B acquisition by St. Jude Medical, and has served on boards of early-stage medical device companies.

n•••@baymedvp.comreveal

Amanda White· Senior Associate

Amanda has more than ten years of medical device industry experience, including seven years at Edwards Lifesciences on transcatheter delivery systems, and was a Stanford Biodesign Innovation Fellow. She served as an investment fellow with Life Science Angels and is currently Senior Manager of Clinical Engineering at NC8. She holds biomedical engineering and economics degrees from Duke University.

Gregg W. Stone, MD· Advisor and clinical key opinion leader

Dr. Stone is a globally recognized leader in medical device technology development, Director of the TCT symposium, and Professor of Medicine at Mount Sinai Heart Health System. He has been principal investigator on more than 120 randomized clinical trials.

Leslie Saxon, MD· Advisor and digital health key opinion leader

Dr. Saxon is Executive Director of the USC Center for Body Computing, a cardiac electrophysiologist, professor, and digital health expert with over 200 peer-reviewed publications. She is a frequent speaker at CES, TEDMED, and SXSW and a recipient of numerous awards.

Martin T. Rothman, MD· Advisor and industry key opinion leader

Dr. Rothman is the former Chief Medical Officer for cardiovascular at Medtronic, co-founder of the British Cardiovascular Intervention Society, and Professor of Interventional Cardiology at Barts Health in London. He is a named inventor on more than 140 patents and an experienced venture partner.

What they invest in

from 11 of 12 portfolio companies

Healthtech ×11Medical Devices ×8Digital Health ×4Biotech ×3Hardware ×3AI & Machine Learning ×1Deep Tech ×1Enterprise Software ×1

HQs:United States×5Israel×1

Investments · 12 tracked

founders shown can be your intro path

By year:2022 · 2 2018 · 13 dated

Append Medicalappendmedical.com in

Append Medical develops a transcatheter system using vacuum-based technology to treat non-valvular atrial fibrillation by occluding the left atrial appendage without implanting a device in the heart.

Deep TechHealthtechMedical Devices

Leonid Sternik(MD, Inventor and cardiac surgeon)

Co-investorsALIVE Israel HealthTech Fund Shoni Health Ventures

AtaCor Medicalatacor.com

Co-investorsArboretum Ventures Broadview Ventures Catalyst Health Ventures Hatteras Venture Partners

Cardiosensecardiosense.com in 𝕏Nov 2022

Cardiosense develops wearable sensing hardware and deep-learning algorithms that convert physiological signals into clinical insights for cardiovascular disease detection and management.

AI & Machine LearningDigital HealthHealthtechMedical DevicesChicago, US

Amit K. Gupta(Executive Officer, Director)Omer Inan(Co-founder, Chief Scientific Officer)Andrew Carek(Co-founder, Chief Technical Officer)Amit Gupta(Co-founder, Advisor (former founding CEO))Mozziyar Etemadi(Co-founder, Head of AI)Omer Tolga Inan(Director)

Co-investorsBroadview Ventures Cross-Border Impact Ventures Laerdal Million Lives Fund OSF Ventures Portal Innovations Hatteras Venture Partners

Deep Bluedeepbluemedical.com in 𝕏

Deep Blue Medical develops surgical devices for soft tissue surgery and hernia repair, including its T-Line Hernia Mesh product line and the T-Line TCS (Tissue Control Suture) for optimal tissue tension, reinforcement, and defect closure.

HealthtechMedical Devices

Co-investorsBand of Angels Duke Capital Partners Wolfpack Investor Network

Embolxembolx.com in 𝕏Oct 2022

Embolx is a commercial-stage medical device company developing microcatheters for arterial embolization procedures used to treat conditions such as cancerous tumors, benign prostatic hyperplasia, and uterine fibroids.

HardwareHealthtechMedical DevicesSunnyvale, US

MICHAEL ALLEN(President & Chief Executive Officer)NORMAN GITIS(Director)PAUL ROGAN(Director)FRANK GRILLO(Director)TIANHONG XU(Director)Michael P. Allen(Executive Officer, Director)

First Light Diagnosticsfirstlightdx.com in 𝕏

First Light Diagnostics develops the MultiPath benchtop analyzer, an instrument for rapid diagnostic testing.

BiotechHealthtechMedical Devices

Co-investorsBoston Harbor Angels LRVHealth

Hillromhillrom.com in

Hillrom, now part of Baxter, develops connected medical devices and clinical systems for hospitals, physician offices, pharmacies and home care, including smart beds, vital signs monitors, infusion pumps, nurse call and communication systems, diagnostic and examination tools, respiratory and surgical technologies, and pharmaceuticals.

Digital HealthHealthtechMedical Devices

Landmark Healthlandmarkhealth.org

Optum Care at Home provides in-home medical care and care navigation services for people enrolled in eligible health plans, including yearly in-home health visits, health screenings, and coordination of benefits like transportation and food assistance.

Digital HealthHealthtechHuntington Beach, US

Michael Huy Le, M.D.(Executive Officer)Adam Boehler(Executive Officer, Director)Eric Van Horn(Executive Officer)Elizabeth Haughton(Executive Officer)Carol De Vol(Executive Officer)Theodore Halkias(Executive Officer)

Co-investorsKhosla Ventures

Thermo Fisher Scientificthermofisher.com in 𝕏Acquired

Thermo Fisher provides life science products and laboratory equipment, including antibodies, consumables, biobanking resources, and Cryo-EM imaging systems for research labs and scientists.

BiotechEnterprise SoftwareHardwareHealthtechWaltham, US

Marc N. Casper(Executive Officer, Director)Andrew J. Thomson(Executive Officer)William G. Parrett(Director)Peter M. Wilver(Executive Officer)Seth H. Hoogasian(Executive Officer)Alan J. Malus(Executive Officer)

Co-investorsARCH Venture Partners Cross Creek Advisors Excel Venture Management Heran Partners Oak HC/FT Domain Associates +1 more

Trisol Medicaltrisol-medical.com in

Trisol Medical develops a transcatheter tricuspid valve replacement device, using a nitinol frame with a dome-shaped leaflet, to treat severe tricuspid regurgitation while preserving right ventricle function.

HardwareHealthtechMedical DevicesYokneam, IL

Mordehay Vaturi(Inventor & Medical Director)Ron Davidson(CEO)Eli Ben-Hamou(VP R&D)Anat Kaufman(VP Regulatory)

BoardShimon Eckhouse(Chairman)

Valfixmedvalfixmed.comAug 2018

VALFIX develops a transcatheter mitral valve repair system with a robotic interface, designed to convert open-heart valve surgery into a minimally invasive transcatheter procedure.

BiotechHealthtechMedical DevicesRoboticsTel Aviv-Yafo

Philip Lavin(Director)Elad Yaacoby(Director)Eli Bar(Executive Officer, Director)

BoardGary Gershony(Director)

Vitaltechvitaltech.com in 𝕏

VitalTech offers an enterprise virtual care coordination platform, including patient apps, caregiver monitoring tools, family access, and business intelligence analytics.

Digital HealthHealthtechSaaS

Co-investorsStanley Ventures

Frequently asked questions

How many investments has BayMed Venture Partners made?: BayMed Venture Partners has 12 tracked investments, 1 of which have exited via acquisition or IPO.
What stage does BayMed Venture Partners invest at?: BayMed Venture Partners invests at the Pre-Seed, Seed, Series A, Series B stages.
What sectors does BayMed Venture Partners focus on?: BayMed Venture Partners focuses on Digital Health, Healthtech, Medical Devices.
Where is BayMed Venture Partners located?: BayMed Venture Partners is headquartered in San Francisco, US.
Who does BayMed Venture Partners co-invest with?: BayMed Venture Partners most often shares deals with Broadview Ventures, Arboretum Ventures, ARCH Venture Partners, among 21 tracked co-investors.

Similar investors

Amadeus Capital Partners

Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.

$50K – $12.7M

B Capital Group

B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.

$10M – $50M

Breyer Capital

Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.

$500K – $10M

DCVC (Data Collective)

DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.

$5M – $25M

Innovestor Ventures

Innovestor is a Finnish investment manager active in venture capital, real estate, and energy storage, and also provides corporate venturing services.

$270K – $3.2M